In 3 × Tg-AD mice, myricetin reduced microglia hyperactivation, encouraged microglia conversion from M1 type to M2 type, and effectively reduced neuroinflammation through reduced IL-1β, TNF-α, and IL-6 expression, whereas increased IL-4 and IL-10. Here, IL1B is linked to Alzheimer disease.